Logo image of GRDN

GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:GRDN - US40145W1018 - Common Stock

28.57 USD
+0.21 (+0.74%)
Last: 11/24/2025, 1:11:36 PM
Fundamental Rating

5

Taking everything into account, GRDN scores 5 out of 10 in our fundamental rating. GRDN was compared to 39 industry peers in the Consumer Staples Distribution & Retail industry. GRDN has an excellent financial health rating, but there are some minor concerns on its profitability. GRDN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year GRDN was profitable.
GRDN had a positive operating cash flow in the past year.
Of the past 5 years GRDN 4 years were profitable.
Each year in the past 5 years GRDN had a positive operating cash flow.
GRDN Yearly Net Income VS EBIT VS OCF VS FCFGRDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With an excellent Return On Assets value of 10.32%, GRDN belongs to the best of the industry, outperforming 87.18% of the companies in the same industry.
GRDN has a Return On Equity of 21.90%. This is in the better half of the industry: GRDN outperforms 71.79% of its industry peers.
GRDN's Return On Invested Capital of 20.33% is amongst the best of the industry. GRDN outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 10.32%
ROE 21.9%
ROIC 20.33%
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
GRDN Yearly ROA, ROE, ROICGRDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

With a decent Profit Margin value of 2.90%, GRDN is doing good in the industry, outperforming 74.36% of the companies in the same industry.
GRDN has a better Operating Margin (4.22%) than 74.36% of its industry peers.
Looking at the Gross Margin, with a value of 19.74%, GRDN is in line with its industry, outperforming 41.03% of the companies in the same industry.
In the last couple of years the Gross Margin of GRDN has remained more or less at the same level.
Industry RankSector Rank
OM 4.22%
PM (TTM) 2.9%
GM 19.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
GRDN Yearly Profit, Operating, Gross MarginsGRDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

7

2. Health

2.1 Basic Checks

GRDN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for GRDN has been increased compared to 1 year ago.
GRDN has more shares outstanding than it did 5 years ago.
GRDN has a better debt/assets ratio than last year.
GRDN Yearly Shares OutstandingGRDN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
GRDN Yearly Total Debt VS Total AssetsGRDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

GRDN has an Altman-Z score of 9.56. This indicates that GRDN is financially healthy and has little risk of bankruptcy at the moment.
GRDN has a better Altman-Z score (9.56) than 97.44% of its industry peers.
GRDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.56
ROIC/WACC2.33
WACC8.72%
GRDN Yearly LT Debt VS Equity VS FCFGRDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

A Current Ratio of 1.22 indicates that GRDN should not have too much problems paying its short term obligations.
GRDN's Current ratio of 1.22 is fine compared to the rest of the industry. GRDN outperforms 64.10% of its industry peers.
GRDN has a Quick Ratio of 1.22. This is a bad value and indicates that GRDN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of GRDN (0.93) is better than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.93
GRDN Yearly Current Assets VS Current LiabilitesGRDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

GRDN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 139.38%, which is quite impressive.
The Revenue for GRDN has decreased by -28.22% in the past year. This is quite bad
The Revenue has been growing by 11.96% on average over the past years. This is quite good.
EPS 1Y (TTM)139.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.5%
Revenue 1Y (TTM)-28.22%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%20.05%

3.2 Future

GRDN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.87% yearly.
The Revenue is expected to grow by 8.69% on average over the next years. This is quite good.
EPS Next Y155.83%
EPS Next 2Y64.99%
EPS Next 3Y41.87%
EPS Next 5YN/A
Revenue Next Year14.6%
Revenue Next 2Y8.17%
Revenue Next 3Y8.69%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GRDN Yearly Revenue VS EstimatesGRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
GRDN Yearly EPS VS EstimatesGRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.5 -0.5 1 -1

4

4. Valuation

4.1 Price/Earnings Ratio

GRDN is valuated quite expensively with a Price/Earnings ratio of 45.35.
GRDN's Price/Earnings ratio is a bit more expensive when compared to the industry. GRDN is more expensive than 66.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.47. GRDN is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 32.32 indicates a quite expensive valuation of GRDN.
The rest of the industry has a similar Price/Forward Earnings ratio as GRDN.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.42, GRDN is valued at the same level.
Industry RankSector Rank
PE 45.35
Fwd PE 32.32
GRDN Price Earnings VS Forward Price EarningsGRDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

66.67% of the companies in the same industry are cheaper than GRDN, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as GRDN.
Industry RankSector Rank
P/FCF 26.54
EV/EBITDA 21.87
GRDN Per share dataGRDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

GRDN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GRDN may justify a higher PE ratio.
A more expensive valuation may be justified as GRDN's earnings are expected to grow with 41.87% in the coming years.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y64.99%
EPS Next 3Y41.87%

0

5. Dividend

5.1 Amount

GRDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GUARDIAN PHRMCY SERVICES-A

NYSE:GRDN (11/24/2025, 1:11:36 PM)

28.57

+0.21 (+0.74%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)03-24 2026-03-24
Inst Owners83.31%
Inst Owner Change10.86%
Ins Owners3.92%
Ins Owner Change33.15%
Market Cap1.81B
Revenue(TTM)1.39B
Net Income(TTM)40.24M
Analysts86
Price Target34.68 (21.39%)
Short Float %5.62%
Short Ratio3.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.47%
Min EPS beat(2)-13.49%
Max EPS beat(2)-11.45%
EPS beat(4)1
Avg EPS beat(4)-7.59%
Min EPS beat(4)-18.3%
Max EPS beat(4)12.89%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.42%
Min Revenue beat(2)2.36%
Max Revenue beat(2)4.48%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)4.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)21.43%
PT rev (3m)24.39%
EPS NQ rev (1m)8.06%
EPS NQ rev (3m)-6.95%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.29%
Revenue NQ rev (1m)3.44%
Revenue NQ rev (3m)3.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 45.35
Fwd PE 32.32
P/S 1.3
P/FCF 26.54
P/OCF 20.56
P/B 9.84
P/tB 21.22
EV/EBITDA 21.87
EPS(TTM)0.63
EY2.21%
EPS(NY)0.88
Fwd EY3.09%
FCF(TTM)1.08
FCFY3.77%
OCF(TTM)1.39
OCFY4.86%
SpS21.95
BVpS2.9
TBVpS1.35
PEG (NY)0.29
PEG (5Y)N/A
Graham Number6.41
Profitability
Industry RankSector Rank
ROA 10.32%
ROE 21.9%
ROCE 25.73%
ROIC 20.33%
ROICexc 24.2%
ROICexgc 49.8%
OM 4.22%
PM (TTM) 2.9%
GM 19.74%
FCFM 4.91%
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
F-Score6
Asset Turnover3.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 91.13%
Cap/Sales 1.43%
Interest Coverage 75.25
Cash Conversion 109.39%
Profit Quality 169.42%
Current Ratio 1.22
Quick Ratio 0.93
Altman-Z 9.56
F-Score6
WACC8.72%
ROIC/WACC2.33
Cap/Depr(3y)87.95%
Cap/Depr(5y)73.67%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)139.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.5%
EPS Next Y155.83%
EPS Next 2Y64.99%
EPS Next 3Y41.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-28.22%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%20.05%
Revenue Next Year14.6%
Revenue Next 2Y8.17%
Revenue Next 3Y8.69%
Revenue Next 5YN/A
EBIT growth 1Y251.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year259.18%
EBIT Next 3Y57.99%
EBIT Next 5YN/A
FCF growth 1Y-26.08%
FCF growth 3Y-5.46%
FCF growth 5Y-0.01%
OCF growth 1Y-18.16%
OCF growth 3Y-0.31%
OCF growth 5Y0.63%

GUARDIAN PHRMCY SERVICES-A / GRDN FAQ

Can you provide the ChartMill fundamental rating for GUARDIAN PHRMCY SERVICES-A?

ChartMill assigns a fundamental rating of 5 / 10 to GRDN.


Can you provide the valuation status for GUARDIAN PHRMCY SERVICES-A?

ChartMill assigns a valuation rating of 4 / 10 to GUARDIAN PHRMCY SERVICES-A (GRDN). This can be considered as Fairly Valued.


Can you provide the profitability details for GUARDIAN PHRMCY SERVICES-A?

GUARDIAN PHRMCY SERVICES-A (GRDN) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for GRDN stock?

The Price/Earnings (PE) ratio for GUARDIAN PHRMCY SERVICES-A (GRDN) is 45.35 and the Price/Book (PB) ratio is 9.84.


Can you provide the expected EPS growth for GRDN stock?

The Earnings per Share (EPS) of GUARDIAN PHRMCY SERVICES-A (GRDN) is expected to grow by 155.83% in the next year.